21-day lockdown – Possible impact on pharma supply chain

Lockdown is necessary to break the chain of coronavirus


The Indian prime minister Narendra Modi announced the central government’s nationwide lockdown for 21 days in an attempt to slow the spread of the coronavirus in the country. Modi ordered all 1.3 billion people in the country to stay inside their homes for three weeks starting Wednesday.

While addressing the nation through television on Tuesday, the prime minister said, “There will be a total ban on venturing out of your homes. Every state, every district, every lane, every village will be under lockdown from Wednesday midnight for 21 days.” This announcement gave Indians less than four hours’ notice before the order took effect at 12:01 am. Earlier also, on 19 March 2020, the prime minister implored all citizens of India to observe a self-imposed ‘curfew’ from 7 am to 9 pm IST on Sunday, 22 March 2020, to help reduce the community spread of the coronavirus disease in India.

Lockdown – A need of the hour

Though the number of reported coronavirus infections in the country is relatively low compared to other nations, including Italy, the United States, Europe or China, if the situation is not kept under control, it would lead to a disaster far bigger than anywhere else.

The total number of reported cases in the country till today is 562, and 10 deaths have been reported due to pandemic. The prime minister also stressed that ‘social distancing’ is the only way to control the spread of the highly contagious infection. He said, “Today India is at the stage where our actions today, will decide to what extent we can bring down the impact of this disaster. If India does not handle these 21 days well, then our country will go backward by 21 years.” According to him, the 21-day lockdown is very necessary to break the chain of coronavirus pandemic.

Disruption in the pharma supply chain

The prime minister also mentioned in his address that during the period of lockdown, goods and services would keep on running. However, the ground reality is a bit different. The 21-day lockdown is hindering the availability of essential goods and medicines across offline and online channels. On the other side, India’s pharma companies are in a panic mode and fear drug and ingredient shortages, as the nationwide lockdown has led to disruption in the supply chain of medicines. According to a report in the Economic Times, there have been instances where policemen on duty are restricting people and goods from reaching their intended destinations. In addition, the restriction on public transport and private vehicles is making it tough for workers to reach manufacturing plants. The reduced number of the workforce at the production plants is, in turn, impacting the production of essential drugs and other healthcare utilities.

Major stakeholders in the pharma and healthcare sector told the Economic Times that they were facing issues getting materials necessary to run manufacturing plants (for example, coal, packaging supplies, raw materials, and more) at the right place as the vehicles are being detained in transit. The workers are finding it difficult to reach their workplaces as they are not getting transport. Some reported that they could not lift their materials as it required individual permissions from the government.

The situation is tough for everyone at this moment, but there is hope that the need will generate new ideas to tackle these problems in the supply chain and facilitate the smooth flow of essential goods.

The impact, resilience, and growth of responsible packaging in a wide region are daily chronicled by Packaging South Asia.

A multi-channel B2B publication and digital platform such as Packaging South Asia is always aware of the prospect of new beginnings and renewal. Its 16-year-old print monthly, based in New Delhi, India has demonstrated its commitment to progress and growth. The Indian and Asian packaging industries have shown resilience in the face of ongoing challenges over the past three years.

As we present our publishing plan for 2023, India’s real GDP growth for the financial year ending 31 March 2023 will reach 6.3%. Packaging industry growth has exceeded GDP growth even when allowing for inflation in the past three years.

The capacity for flexible film manufacturing in India increased by 33% over the past three years. With orders in place, we expect another 33% capacity addition from 2023 to 2025. Capacities in monocartons, corrugation, aseptic liquid packaging, and labels have grown similarly. The numbers are positive for most of the economies in the region – our platform increasingly reaches and influences these.

Even given the disruptions of supply chains, raw material prices, and the challenge of responsible and sustainable packaging, packaging in all its creative forms and purposes has significant headroom to grow in India and Asia. Our context and coverage engulf the entire packaging supply chain – from concept to shelf and further – to waste collection and recycling. We target brand owners, product managers, raw material suppliers, packaging designers and converters, and recyclers.

In an admittedly fragmented and textured terrain, this is the right time to plan your participation and marketing support communication – in our impactful and highly targeted business platform. Tell us what you need. Speak and write to our editorial and advertising teams! For advertisement ads1@ippgroup.in , for editorial info@ippgroup.in and for subscriptions subscription@ippgroup.in

– Naresh Khanna

Subscribe Now
unnamed 1


Subscribe to our Newsletter

As 2023 begins and FY 23-24 unfolds, will you support us?

What lies in store for the packaging industry in India and South Asia this coming year? Inflation, disruption of supply chains or environmental regulation? Or the resumption of high rural demand, continued investment and industry consolidation? Whatever happens, Packaging South Asia will be there, providing clarity and independent technical and business information in India and South Asia and around the world. We are a compact Indian organization bringing a window of fair and rigorous technical and business information that the industry can access this year and beyond. Please support us with your advertising and subscriptions, to keep us going and growing.

Thank you.

Previous articleB&R Moll deemed essential business amid coronavirus outbreak
Next articleMahindra to make ventilators to combat Coronavirus outbreak
Technical Editor - Mandeep Kaur is working with IPP Group and holding editorial responsibilities for the IndiFoodBev and PSA Healthcare platforms. Earlier she handled editorial responsibilities of food, beverage, and agriculture publications at another publisher. A gold-medalist in M Tech (Food Technology), she has hands-on experience in operating different types of instruments related to physico-chemical testing of grains and flour. She has worked at Evalueserve in the Intellectual Property (IP) division for more than three years handling projects in the life sciences domain.


Please enter your comment!
Please enter your name here